Back to Search
Start Over
Relapsed or Refractory Diffuse Large B-cell Lymphoma Markets, 2028
- Source :
- M2 Presswire. May 27, 2021
- Publication Year :
- 2021
-
Abstract
- M2 PRESSWIRE-May 27, 2021-: Relapsed or Refractory Diffuse Large B-cell Lymphoma Markets, 2028 (C)1994-2021 M2 COMMUNICATIONS RDATE:27052021 The 'Relapsed or Refractory Diffuse Large B-cell Lymphoma Market - Size, Share, Outlook, [...]
- Subjects :
- United States. Food and Drug Administration -- Reports
ADC Therapeutics S.A. -- Forecasts and trends
Novartis AG -- Forecasts and trends
Lymphomas -- Reports -- Forecasts and trends
Biotechnology industry -- Forecasts and trends
Pharmaceutical industry -- Forecasts and trends
Market trend/market analysis
Business
Business, international
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Presswire
- Publication Type :
- News
- Accession number :
- edsgcl.663199583